Ten-year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT randomized controlled trial according to treatment received
European Urology Dec 04, 2019
Neal DE, Metcalfe C, Donovan JL, et al. - Men with clinically localized prostate cancer at one of nine UK centers were invited to take part in a treatment trial comparing active monitoring (AM), radical prostatectomy, and radiotherapy in order to assess outcomes according to treatment. Analyses according to treatment received revealed raised rates of disease-related events and cheaper rates of patient-reported harms in men managed by AM in comparison with men managed by radical treatment, and more substantial proof of more comprehensive prostate cancer mortality in the AM group.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data